Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Safety and tolerability of pirfenidone (PFD) in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD)-The LOTUSS study Khanna, D., Albera, C., Fischer, A., Seibold, J., Raghu, G., Khalidi, N., Chung, L., Schiopu, E., Chen, D., Gorina, E. EUROPEAN RESPIRATORY SOC JOURNALS LTD. 2015
View details for DOI 10.1183/13993003.congress-2015.OA4489
View details for Web of Science ID 000451979400370